Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Ranclav
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ranclav 125mg/31mg/5ml SF oral suspension
0501013K0BDADAD
|
Ranclav | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | No data available |
|
Ranclav 250mg/62mg/5ml SF oral suspension
0501013K0BDACAG
|
Ranclav | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | No data available |
|
Ranclav 375mg tablets
0501013K0BDAAAA
|
Ranclav | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | No data available |
|
Ranclav 625mg tablets
0501013K0BDABAJ
|
Ranclav | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.